Blog
Credo Technology Before Q4 Earnings: Should Investors Buy the Stock?
Credo Technology Group Holding Ltd CRDO is scheduled to report fourth-quarter fiscal 2026 results on June 1, after the closing bell.
The Zacks Consensus Estimate for the bottom line for the
Energy ETFs Could Be Positioned for More Gains: Here's Why
Volatility in oil prices has remained a defining feature of global markets ever since the onset of the Middle East conflict. Against this backdrop, energy ETFs continue to stand out as a segment
IRWD's Linzess Wins FDA Nod for Expanded Pediatric Constipation Use
Ironwood Pharmaceuticals IRWD announced that the FDA has approved the expanded use of its sole marketed drug, Linzess (linaclotide), for the treatment of functional constipation (FC) in pediatric
AbbVie Wins FDA Nod for Decnupaz for Rare Blood Cancer Indication
AbbVie ABBV announced the FDA approval of Decnupaz (pivekimab sunirine-pvzy) for the treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN). The disease is an
Petrobras Plans Major Gas Production Growth in the Amazon Region
Petrobras PBR, the Brazilian state-controlled integrated oil and gas company, has announced a bold plan to resume substantial investments in the Urucu natural gas hub, located in the Solimões Basin
Here's How IonQ's Expanding Commercial Traction Is Driving Its 2026 Outlook
In the first quarter, IonQ IONQ delivered robust revenue growth of 755% year over year, driven by strong demand for its industry-leading quantum computing systems and the growing commercial traction
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon’s ALC Vision Care business continues to gain from its diverse portfolio of contact lenses and ocular health products. Growth momentum within the Surgical business is poised to boost the top
Ciena (CIEN) Earnings Expected to Grow: Should You Buy?
Wall Street expects a year-over-year increase in earnings on higher revenues when Ciena (CIEN) reports results for the quarter ended April 2026. While this widely-known consensus outlook is
Brown-Forman B (BF.B) Reports Next Week: Wall Street Expects Earnings Growth
Wall Street expects a year-over-year increase in earnings on lower revenues when Brown-Forman B (BF.B) reports results for the quarter ended April 2026. While this widely-known consensus outlook is
Earnings Preview: Lululemon (LULU) Q1 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on higher revenues when Lululemon (LULU) reports results for the quarter ended April 2026. While this widely-known consensus outlook is
Caleres Inc. (CAL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Caleres Inc. (CAL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended April 2026. This widely-known consensus
Analysts Estimate Quanex Building Products (NX) to Report a Decline in Earnings: What to Look Out for
Quanex Building Products (NX) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended April 2026. This widely-known consensus
Best Momentum Stock to Buy for May 28th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, May 28th:
Helios Technologies HLIO: This company, which is a global provider of highly
What's Ollie's Bargain Probability of an Earnings Beat This Season?
With Ollie's Bargain Outlet Holdings, Inc. OLLI set to announce its first-quarter 2026 earnings results on June 3, before the market opens, investors are focused on whether the extreme value
HCA Healthcare to Acquire CHCP to Strengthen Workforce Development
HCA Healthcare, Inc. HCA has agreed to acquire The College of Health Care Professions (“CHCP”), a Texas-based allied healthcare training provider. CHCP serves more than 8,000 students annually
ETFs Primed for Gains on NVIDIA's $150B AI Spending Vow in Taiwan
NVIDIA’s NVDA CEO Jensen Huang announced that the technology giant plans to ramp up its annual spending and investments in Taiwan to a staggering $150 billion. This massive commitment marks a
QIAGEN Business Breakdown and Growth Drivers for 2026
QIAGEN QGEN has built a broad assay and biomarker portfolio that spans pre-analytical sample preparation and molecular diagnostics. That mix gives the company multiple shots on goal across clinical
JPMorgan's $20B Deal War Chest: What It Means for JPM Stock
JPMorgan JPM is once again signaling that it has the financial muscle to pursue a major acquisition, with CEO Jamie Dimon indicating the banking giant could deploy as much as $20 billion for the
Wall Street Analysts Predict a 48.79% Upside in HCI Group (HCI): Here's What You Should Know
Shares of HCI Group (HCI) have gained 0.3% over the past four weeks to close the last trading session at $155.7, but there could still be a solid upside left in the stock if short-term price targets
Wall Street Analysts Think NioCorp Developments Ltd. (NB) Could Surge 100.7%: Read This Before Placing a Bet
Shares of NioCorp Developments Ltd. (NB) have gained 2.7% over the past four weeks to close the last trading session at $5.73, but there could still be a solid upside left in the stock if short-term
Wall Street Analysts Predict a 42.62% Upside in EuroDry (EDRY): Here's What You Should Know
EuroDry (EDRY) closed the last trading session at $23.37, gaining 18.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Believe Ivanhoe Electric (IE) Could Rally 58.28%: Here's is How to Trade
Shares of Ivanhoe Electric (IE) have gained 5.9% over the past four weeks to close the last trading session at $13.04, but there could still be a solid upside left in the stock if short-term price
How Much Upside is Left in Open Text (OTEX)? Wall Street Analysts Think 30.66%
Open Text (OTEX) closed the last trading session at $23.03, gaining 3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street
Wall Street Analysts Think Quad/Graphics (QUAD) Could Surge 34.19%: Read This Before Placing a Bet
Quad/Graphics (QUAD) closed the last trading session at $7.4, gaining 5.6% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall



